Filing Details
- Accession Number:
- 0001209191-23-057989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-08 19:20:21
- Reporting Period:
- 2023-12-07
- Accepted Time:
- 2023-12-08 19:20:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419041 | Forte Biosciences Inc. | FBRX | Pharmaceutical Preparations (2834) | 261243872 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612842 | A. Paul Wagner | C/O Forte Biosciences, Inc. 3060 Pegasus Park Dr., Bldg 6 Dallas TX 75247 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-07 | 36,203 | $0.58 | 1,747,940 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-12-08 | 15,000 | $0.62 | 1,762,940 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 36,203 shares purchased in the price range of $0.54 to $0.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.6085 to $0.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
